Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind Phase III study of zonisamide (AD-810N) in Parkinson's disease with wearing-off
jRCT2080221162Phase 3
- Sponsor
- Sumitomo Pharma
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of zonisamide in Parkinson's disease (PD) (2 arms), sponsored by Sumitomo Pharma.
02
Drugs
zonisamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080221162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221162.